Sartorius Stedim Biotech S.A.
SDMHF
$193.02
-$26.41-12.04%
OTC PK
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 13.28% | 50.79% | 11.76% | 0.22% | |
| Total Depreciation and Amortization | -10.13% | 10.26% | -0.21% | 1.14% | |
| Total Amortization of Deferred Charges | 35.34% | -- | 77.05% | -- | |
| Total Other Non-Cash Items | 202.21% | -31.76% | -71.79% | 1,730.90% | |
| Change in Net Operating Assets | -53.16% | -253.05% | -15.87% | 12,973.04% | |
| Cash from Operations | -5.51% | -39.11% | -16.04% | 165.35% | |
| Capital Expenditure | -59.85% | 0.21% | 22.95% | 34.70% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -828.24% | -- | 91.75% | -- | |
| Cash from Investing | -61.77% | -1.11% | 24.52% | 96.95% | |
| Total Debt Issued | -89.19% | -5.15% | -- | -100.00% | |
| Total Debt Repaid | 100.00% | 100.00% | 91.91% | 85.19% | |
| Issuance of Common Stock | 50.00% | -- | 55.56% | 93.75% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -5.44% | -- | -- | |
| Other Financing Activities | 57.95% | 99.27% | 91.47% | -10,991.67% | |
| Cash from Financing | 108.62% | 85.06% | 94.72% | -107.26% | |
| Foreign Exchange rate Adjustments | -142.27% | -251.48% | 667.42% | 133.67% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -29.16% | 96.32% | 1,024.07% | 369.04% | |